Co-founder and CEO Jeff Green said the quarter “represented meaningful progress, with results well ahead of our expectations entering the quarter,” even as he acknowledged the company remains “below the level of growth we expect from ourselves.”
CEO Badri Kothandaraman attributed the drop in U.S. sell-through to elevated interest rates and the expiration of tax credits on renewable energy system installations.
Deutsche Bank analyst Corinne Blanchard said elevated interest rates are weighing on SolarEdge products’ U.S. demand and sees risk to fourth-quarter and 2027 earnings.
The Food and Drug Administration (FDA) cleared a 120-milligram prefilled syringe that copies Ipsen’s Somatuline Depot, a long-acting under-the-skin injection.
One of Wendy’s franchisees, operating 314 Wendy’s restaurants across 15 states, or about 5% of Wendy’s U.S. system, filed a voluntary Chapter 11 petition on Thursday.